Locations:
Search IconSearch

News & Insight

fears_650x450
October 9, 2017/Cancer/News & Insight

At-Risk Breast Cancer Patients Benefit from Psychosocial Counseling

Carrying the gene confers the same fears as a diagnosis

650×450-Cleveland-Clinic-Cancer
August 1, 2017/Cancer/News & Insight

Enasidenib Effective Treatment for Refractory Acute Myeloid Leukemia

Precision therapy for refractory disease now FDA approved

Dr.Kalaycia_650x450
June 14, 2017/Cancer/News & Insight

The Basics of High Reliability

A Cleveland Clinic physician defines the elusive term

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

newdrug_690x380 cancer
April 9, 2015/Cancer/News & Insight

FDA OKs Zarxio as First Biosimilar Drug

Approval may spur competition, cost savings

BackPage 10 of 10Next

Advertisement

Ad